Shenzhen, China

Longgui Zhang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Longgui Zhang. Retrieved from https://idiyas.com/inventor/longgui-zhang-9n4t933a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Longgui Zhang: Innovator in Lipid Nanoparticle Formulations

Introduction

Longgui Zhang is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of lipid nanoparticle formulations. His work focuses on innovative methods for delivering nucleic acids, such as mRNA, which are crucial for various therapeutic applications.

Latest Patents

Longgui Zhang holds 1 patent related to lipids and lipid nanoparticle formulations. This patent outlines the methods and compositions for effectively delivering nucleic acids, enhancing the potential for mRNA-based therapies. His innovative approach is paving the way for advancements in drug delivery systems.

Career Highlights

Longgui Zhang is associated with Longuide Biopharma Corporation, where he applies his expertise in lipid formulations. His career is marked by a commitment to advancing biopharmaceutical technologies and improving patient outcomes through innovative delivery methods.

Collaborations

He collaborates with talented individuals in his field, including Yuebao Zhang and Chen Liu. These partnerships enhance the research and development efforts at Longuide Biopharma Corporation, fostering a collaborative environment for innovation.

Conclusion

Longgui Zhang is a key figure in the development of lipid nanoparticle formulations, contributing to the future of mRNA delivery systems. His work exemplifies the importance of innovation in the biopharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…